RESUMO
Five prepared catering dishes were analysed to evaluate the proximate composition and the fatty acids, vitamin E, thiamine and riboflavin content. The correspondent values were calculated from actually available food composition tables (two from Italy, one from the UK and one from the USA). When using more than one database to calculate the composition of a complex recipe the average values were similar to the analytical ones despite the wide range reported for some variables. However, there was no significant difference in the statistical analyses between the analytical values and databases, or among the databases themselves. Therefore if the composition of a specific recipe is required, analyses would be advisable, but the available databases are quite adequate if the evaluation is for groups of people, even allowing for the seasonal variability of ingredients.
Assuntos
Análise de Alimentos , Manipulação de Alimentos , Análise de Variância , Cromatografia Gasosa , Bases de Dados Factuais , Humanos , Valor NutritivoAssuntos
Doença das Coronárias/tratamento farmacológico , Perexilina/uso terapêutico , Piperidinas/uso terapêutico , Administração Oral , Idoso , Alanina Transaminase/sangue , Angina Pectoris/tratamento farmacológico , Animais , Arritmias Cardíacas/tratamento farmacológico , Aspartato Aminotransferases/sangue , Ensaios Clínicos como Assunto , Doença das Coronárias/sangue , Relação Dose-Resposta a Droga , Avaliação de Medicamentos , Eletrocardiografia , Feminino , Ventrículos do Coração/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Contração Miocárdica/efeitos dos fármacos , Nitroglicerina/uso terapêutico , Consumo de Oxigênio , Perexilina/administração & dosagem , Perexilina/farmacologia , PrognósticoRESUMO
43 subjects, affected by chronic aggressive hepatitis (CAH) have been divided into two groups according to the presence of HBAg. No statistically significant differences between the two groups have been provided. The two classes of subjects (HBAg + and -) were also divided into the already treated (with immunosuppressive drugs) and untreated to investigate the eventual differences existing between the two classes. The results of this division was that previously treated subjects present a lower total bilirubin (P less than 0.05) in respect to those that were not treated previously. The results of all the other comparisons carried out and the tested correlations were negligible. In conclusion, bearing in mind the inadequate methods used up to now to research the HBAg, the transversal studies show that CAH patients are both affected by the same syndrome, whether the HBAg is positive or negative. However, it is probable that it is not the carrier state of HBAg which enables the liver disease evolution but the liver disease itself enables the cellular immunity disorders that often appear in the course of CAH.
Assuntos
Antígenos da Hepatite B/isolamento & purificação , Hepatite B/imunologia , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Anticorpos Antivirais/isolamento & purificação , Formação de Anticorpos , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Butirilcolinesterase/sangue , Doença Crônica , Hepatite B/sangue , Hepatite B/enzimologia , Humanos , Imunoglobulinas/análise , RadioimunoensaioRESUMO
The pharmacological evaluation of the diuretic activity of a compound -- performed measuring the urinary volume and determining its electrolyte content -- may be usefully integrated by a multivariate analysis, in order to: express a general evaluation for each animal in terms of positive or negative response; evaluate the false positive responses of the control group animals and the negative responses in the treated animals on the basis of the general response. An example of application relating to a well-known saluretic, 4-chloro-N-(2-furfuryl)-5-sulfamoyl-anthranilic acid (furosemide), is reported.
